|
C17ORF65 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.74809996980707E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.21500000008312E-07 |
| Normal-vs-Stage2 |
3.297100E-03 |
| Normal-vs-Stage3 |
6.364600E-04 |
| Normal-vs-Stage4 |
1.171570E-01 |
| Stage1-vs-Stage2 |
7.340000E-01 |
| Stage1-vs-Stage3 |
8.930200E-01 |
| Stage1-vs-Stage4 |
9.296600E-01 |
| Stage2-vs-Stage3 |
8.487600E-01 |
| Stage2-vs-Stage4 |
9.048000E-01 |
| Stage3-vs-Stage4 |
9.971000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.50819978307038E-10 |
| Normal-vs-AfricanAmerican |
8.573000E-04 |
| Normal-vs-Asian |
1.126810E-01 |
| Caucasian-vs-AfricanAmerican |
4.258400E-02 |
| Caucasian-vs-Asian |
3.297000E-01 |
| AfricanAmerican-vs-Asian |
3.191000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.16599998731959E-09 |
| Normal-vs-Female |
4.10459999988788E-07 |
| Male-vs-Female |
6.811800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.398660E-03 |
| Normal-vs-Extreme_Weight |
4.19809999985254E-07 |
| Normal-vs-Obese |
4.34530000004152E-06 |
| Normal-vs-Extreme_Obese |
8.009600E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.125200E-01 |
| Normal_Weight-vs-Obese |
3.542000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.793600E-01 |
| Extreme_Weight-vs-Obese |
7.985000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.647400E-01 |
| Obese-vs-Extreme_Obese |
8.698200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.587200E-04 |
| Normal-vs-Age(41-60Yrs) |
4.60669946633629E-10 |
| Normal-vs-Age(61-80Yrs) |
1.65119999995245E-06 |
| Normal-vs-Age(81-100Yrs) |
3.436600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.336550E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.997700E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.460000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.977600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.340180E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.260970E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.11684011933266E-12 |
| Normal-VS-Type2 PRCC |
3.602500E-02 |
| Normal-VS-KIRP CIMP |
1.86608999999116E-05 |
| Normal-VS-Unclassified PRCC |
1.828590E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.56480000004888E-06 |
| Type1 PRCC-VS-KIRP CIMP |
4.497200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.739770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.363300E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.508300E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.659400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.2487E-05 |
| Normal-vs-N1 |
2.421300E-03 |
| Normal-vs-N2 |
1.257410E-01 |
| N0-vs-N1 |
2.659000E-01 |
| N0-vs-N2 |
6.941400E-01 |
| N1-vs-N2 |
4.740600E-01 |
|
|
